115 related articles for article (PubMed ID: 8258822)
1. Three-dimensional quantitative structure-activity relationships of 5-HT receptor binding data for tetrahydropyridinylindole derivatives: a comparison of the Hansch and CoMFA methods.
Agarwal A; Pearson PP; Taylor EW; Li HB; Dahlgren T; Herslöf M; Yang Y; Lambert G; Nelson DL; Regan JW
J Med Chem; 1993 Dec; 36(25):4006-14. PubMed ID: 8258822
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit.
Taylor EW; Nikam SS; Lambert G; Martin AR; Nelson DL
Mol Pharmacol; 1988 Jul; 34(1):42-53. PubMed ID: 3393140
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
[TBL] [Abstract][Full Text] [Related]
4. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
Doddareddy MR; Cho YS; Koh HY; Pae AN
Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a new model of arylpiperazines. 2. Three-dimensional quantitative structure-activity relationships of hydantoin-phenylpiperazine derivatives with affinity for 5-HT1A and alpha 1 receptors. A comparison of CoMFA models.
López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Fernández E; Schaper KJ
J Med Chem; 1997 May; 40(11):1648-56. PubMed ID: 9171874
[TBL] [Abstract][Full Text] [Related]
6. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT(4) receptor antagonists.
López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
J Med Chem; 2002 Oct; 45(22):4806-15. PubMed ID: 12383006
[TBL] [Abstract][Full Text] [Related]
8. Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D quantitative structure-activity relationship (QSAR) Models.
Nicolotti O; Pellegrini-Calace M; Altomar C; Carotti A; Carrieri A; Sanz F
Curr Med Chem; 2002 Jan; 9(1):1-29. PubMed ID: 11864064
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
[TBL] [Abstract][Full Text] [Related]
10. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor.
López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
Bioorg Med Chem Lett; 2001 Nov; 11(21):2807-11. PubMed ID: 11597405
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes.
Stjernlöf P; Ennis MD; Hansson LO; Hoffman RL; Ghazal NB; Sundell S; Smith MW; Svensson K; Carlsson A; Wikström H
J Med Chem; 1995 Jun; 38(12):2202-16. PubMed ID: 7783152
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization.
Waller CL; McKinney JD
Chem Res Toxicol; 1995 Sep; 8(6):847-58. PubMed ID: 7492734
[TBL] [Abstract][Full Text] [Related]
13. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.
Ennis MD; Stjernlöf P; Hoffman RL; Ghazal NB; Smith MW; Svensson K; Wikström H; Haadsma-Svensson SR; Lin CH
J Med Chem; 1995 Jun; 38(12):2217-30. PubMed ID: 7783153
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking and 3D-QSAR CoMFA studies on indole inhibitors of GIIA secreted phospholipase A(2).
Mouchlis VD; Mavromoustakos TM; Kokotos G
J Chem Inf Model; 2010 Sep; 50(9):1589-601. PubMed ID: 20795712
[TBL] [Abstract][Full Text] [Related]
16. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
17. Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines.
Bromidge SM; Dabbs S; Davies DT; Duckworth DM; Forbes IT; Ham P; Jones GE; King FD; Saunders DV; Starr S; Thewlis KM; Wyman PA; Blaney FE; Naylor CB; Bailey F; Blackburn TP; Holland V; Kennett GA; Riley GJ; Wood MD
J Med Chem; 1998 May; 41(10):1598-612. PubMed ID: 9572885
[TBL] [Abstract][Full Text] [Related]
18. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
19. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
[TBL] [Abstract][Full Text] [Related]
20. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
